Chinese Academy of Medical Sciences
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2004-07-08
- Employees
- -
- Market Cap
- -
Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients
- First Posted Date
- 2012-08-29
- Last Posted Date
- 2015-02-05
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT01674959
- Locations
- 🇨🇳
Dept of Radiation oncology, Cancer Hospital , Chinese Academy of Medical Science, Beijing, Beijing, China
Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer
- First Posted Date
- 2012-08-17
- Last Posted Date
- 2012-08-22
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT01667211
- Locations
- 🇨🇳
Chinese Academy of Medical Sciences, Cancer Hospital, Gynecologic Oncology, Beijing, China
A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity
- First Posted Date
- 2012-04-26
- Last Posted Date
- 2013-08-15
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT01586117
- Locations
- 🇨🇳
Radiation Oncology Depratment, Cancer Hospital, CAMS, Beijing, Beijing, China
Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer
- First Posted Date
- 2012-04-25
- Last Posted Date
- 2015-04-20
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 24
- Registration Number
- NCT01584544
- Locations
- 🇨🇳
radiation department, Cancer Hospital, CAMS, Beijing, Beijing, China
Endoscopic Ultrasound Predict the Sensitivity of Stage II / III Rectal Cancer Preoperative Concurrent Chemoradiotherapy
- Conditions
- First Posted Date
- 2012-04-23
- Last Posted Date
- 2013-09-19
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT01582750
- Locations
- 🇨🇳
Li Ning, Beijing, Beijing, China
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer
- First Posted Date
- 2012-03-02
- Last Posted Date
- 2016-06-14
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 71
- Registration Number
- NCT01542294
- Locations
- 🇨🇳
Department of Medical Oncology,Cancer hospital and Institute,CAMS, Beijing, China
The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer
- First Posted Date
- 2012-02-13
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 43
- Registration Number
- NCT01531452
- Locations
- 🇨🇳
cancer hospital & Institute,Chinese Academy of Medical Sciences, Beijing, Beijing, China
Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2012-02-08
- Last Posted Date
- 2013-11-27
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 51
- Registration Number
- NCT01529164
- Locations
- 🇨🇳
Cancer hospital & Institute,Chinese Academy of Medical Sciences, Beijing, Beijing, China
Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease
- Conditions
- Interventions
- First Posted Date
- 2012-02-06
- Last Posted Date
- 2012-08-03
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT01526850
- Locations
- 🇨🇳
Zhejiang University, Hangzhou, Zhejiang, China
Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)
- First Posted Date
- 2012-01-04
- Last Posted Date
- 2012-01-04
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT01503385
- Locations
- 🇨🇳
Jun Liang, Beijing, Beijing, China
🇨🇳Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China